Excessive sweating is not always limited to the underarms. The hands, feet, face, scalp, groin, chest, and back can also be affected, which raises an important question: can miraDry treat these areas too?
Can miraDry Be Used on the Hands?
No. miraDry is not FDA-cleared or designed to treat palmar hyperhidrosis.
The palm is very different from the underarm. Palmar skin has a thick outer layer, is firmly connected to the tissues beneath it, and contains a dense network of sensory receptors. Tendons, nerves, blood vessels, and other structures essential to hand movement and sensation must also be considered. The palm’s curved surface and deep creases do not match the axillary treatment template or the intended contact area of the miraDry handpiece.
Because miraDry’s clinical evidence relates to underarm treatment, there is no established protocol showing which device settings, tissue preparation, treatment pattern, or cooling approach would be safe and effective for the palms. Palmar sweating is better addressed with therapies that have specific clinical support for the hands.
Common Alternatives for Sweaty Hands
- Clinical-strength or prescription antiperspirants: Aluminum salt preparations temporarily obstruct sweat ducts and are often tried first for mild focal sweating.
- Tap-water iontophoresis: The hands are placed in shallow trays of water while a low electrical current passes through the water. Treatment is repeated initially and then continued on a maintenance schedule.
- Botulinum toxin injections: Carefully placed injections temporarily block the release of acetylcholine, the chemical messenger that activates sweat glands. Treatment can be effective but may be uncomfortable, and temporary hand-muscle weakness is a recognized risk.
- Oral medication: A medical provider may consider an anticholinergic medication when local treatment is insufficient or several areas are affected.
Can miraDry Be Used on the Feet?
No. miraDry is not FDA-cleared or designed to treat plantar hyperhidrosis.
Like the palms, the soles have a thick outer skin layer, prominent curves, and numerous sensory structures. They are also exposed to pressure and friction with every step. Even a temporary period of swelling, blistering, tenderness, or altered sensation could substantially interfere with walking and wearing shoes.
No standard miraDry template or FDA-reviewed treatment protocol exists for the soles. The depth and distribution of sweat glands, the shape of the treatment surface, and the demands placed on weight-bearing skin make the underarm protocol unsuitable for direct transfer to the feet.
Common Alternatives for Sweaty Feet
- Prescription-strength antiperspirants: Often used as an initial option when applied to completely dry skin as directed.
- Iontophoresis: Foot trays allow both soles to be treated with a mild electrical current. Ongoing maintenance is generally required.
- Botulinum toxin injections: These may temporarily reduce plantar sweating, although injections into the soles can be painful and usually require careful pain-control planning.
- Foot-care measures: Moisture-wicking socks, breathable shoes, rotating footwear, and treatment of fungal or bacterial skin conditions can help manage the effects of excessive sweating, although they do not directly reduce sweat-gland activity.
Can miraDry Be Used on the Face or Scalp?
No. miraDry should not be used on the face or scalp. It is not FDA-cleared for craniofacial hyperhidrosis, and the axillary device design is not intended for facial anatomy.
The face contains superficial motor and sensory nerves, blood vessels, salivary glands, and the eyes. Its many curves also prevent the consistent template placement and handpiece contact used in the underarms. The scalp has different tissue thicknesses and contours, along with dense hair, sensory nerves, and blood vessels.
Craniofacial sweating requires careful diagnosis. It may involve the forehead, scalp, upper lip, or one side of the face and may be triggered by heat, stress, food, medication, menopause, a neurological condition, or another medical issue. The cause and precise location help determine the safest treatment option.
Common Alternatives for Facial or Scalp Sweating
- Topical glycopyrrolate or another clinician-selected topical therapy: Published evidence supports topical glycopyrrolate for craniofacial hyperhidrosis, but a qualified medical provider should determine the formulation and application area. Care is needed to prevent the medication from getting into the eyes.
- Botulinum toxin injections: Small, precisely placed doses may reduce sweating in selected facial or scalp areas. Treatment must be planned around facial muscles to reduce the risk of temporary asymmetry or unwanted muscle weakness.
- Oral anticholinergic medication: This may be considered for broader or difficult-to-treat sweating, with medical supervision because side effects can include dry mouth, blurred vision, constipation, urinary retention, and reduced ability to cool the body.
Can miraDry Be Used on the Groin?
No. miraDry is not FDA-cleared or designed for the groin, pubic area, genital skin, or buttocks.
“Groin sweating” can describe several locations, including the skin folds where the legs meet the torso, the pubic area, external genital skin, or the area between the buttocks. These sites differ significantly in skin thickness, moisture, friction, sensitivity, hair distribution, and proximity to nerves and other delicate structures.
There is no standardized FDA-cleared miraDry template, energy protocol, anesthesia technique, or established body of clinical safety evidence for these areas. A moist, high-friction area could also make swelling, blistering, or a wound more difficult to protect while it heals. For these reasons, Injector 5280 does not perform miraDry treatment in the groin.
Common Alternatives for Groin Sweating
- Medical evaluation: A clinician should first distinguish hyperhidrosis from odor, urine leakage, infection, intertrigo, hidradenitis suppurativa, or another skin or medical condition.
- Carefully selected topical treatment: A clinician may recommend an antiperspirant or prescription topical medication suitable for a specific external skin area. Products should not be applied to mucosal or irritated skin unless specifically directed.
- Oral medication: An anticholinergic may be considered when sweating affects a broad area or several body sites.
- Practical moisture control: Breathable clothing, moisture-wicking underwear, barrier products, and changing promptly after exercise may reduce irritation and odor while the underlying sweating is assessed.
Can miraDry Be Used on the Chest, Breasts, Abdomen, or Back?
miraDry is not FDA-cleared for the chest, beneath the breasts, abdomen, or back. These larger areas do not have an approved miraDry mapping system or established treatment protocol. Their contours, skin and fat thickness, sweat-gland distribution, and nearby anatomical structures vary considerably.
Sweating over a large portion of the torso may represent generalized or secondary hyperhidrosis rather than a single focal treatment area. In that situation, treating the sweat glands in one small area would not address the underlying cause. A medical assessment is more appropriate.
Safe and Evidence-Based Alternatives by Treatment Area
| Body Area | Options Commonly Considered | Important Considerations |
|---|---|---|
| Hands | Antiperspirants, iontophoresis, botulinum toxin, oral medication | Iontophoresis requires maintenance. Botulinum toxin can cause temporary discomfort or hand weakness. |
| Feet | Antiperspirants, iontophoresis, botulinum toxin, oral medication | Sole injections can be painful. Footwear and skin infections may also need attention. |
| Face or Scalp | Clinician-directed topical therapy, botulinum toxin, oral medication | Topicals must be kept away from the eyes. Injection placement must account for facial muscles. |
| Groin | Diagnosis first, carefully selected topicals, oral medication, moisture-control measures | External skin, folds, and mucosal tissue require different care. Irritation or infection may mimic or accompany sweating. |
| Chest, Back, or Multiple Areas | Medical evaluation, topicals where appropriate, oral medication, treatment of an underlying cause | Broad, new, or nighttime sweating may indicate secondary hyperhidrosis. |
There is no single best treatment for every patient. Even commonly used therapies may be off-label for a particular product or body area. A qualified clinician should confirm the diagnosis, explain the strength of the evidence, review contraindications, and tailor treatment to the area involved.
Which Areas Is miraDry FDA-Cleared to Treat?
The original U.S. Food and Drug Administration clearance states that the miraDry System is indicated for primary axillary hyperhidrosis and is not indicated for hyperhidrosis affecting other body areas or for generalized hyperhidrosis.[1] Later clearances added permanent underarm hair reduction and noted that treatment of axillary hyperhidrosis may also reduce underarm odor.[2][3]
- Underarm sweat: FDA-cleared for the treatment of primary axillary hyperhidrosis.
- Underarm hair: FDA-cleared for permanent reduction of unwanted underarm hair within the cleared treatment parameters.
- Underarm odor: FDA labeling states that the system may reduce underarm odor when used to treat primary axillary hyperhidrosis.
- Other body areas: Not included in the FDA-cleared indications.
FDA clearance identifies the intended treatment area evaluated using the device’s specific design, operating parameters, and clinical protocol. Treatment performed elsewhere would be an off-label use, and the results and safety data from underarm treatment should not be assumed to apply to another part of the body.
The Bottom Line
miraDry is FDA-cleared and designed specifically for the underarms (axillae). It is not FDA-cleared for the hands, feet, face, scalp, groin, breasts, chest, back, or generalized sweating.
At Injector 5280, we use miraDry only for the underarm area for which the system was developed and clinically evaluated.
Clinical References
- U.S. Food and Drug Administration: miraDry System 510(k) Summary and Indications for Use (K103014).
- U.S. Food and Drug Administration: miraDry MD4000 Clearance for Axillary Hyperhidrosis and Underarm Hair Reduction (K150419).
- U.S. Food and Drug Administration: miraDry MD4000 Labeling Including Underarm Odor Reduction (K160141).
- Hong HC, Lupin M, O’Shaughnessy KF. Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis. Dermatologic Surgery. 2012.
- McConaghy JR, Fosselman D. Hyperhidrosis: Management Options. American Family Physician. 2018.
- Rajagopal R, Mallya NB. Comparative Evaluation of Botulinum Toxin Versus Iontophoresis With Topical Aluminum Chloride Hexahydrate in Palmar Hyperhidrosis. Medical Journal Armed Forces India. 2014.
- Nicholas R, Quddus A, Baker DM. Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review. American Journal of Clinical Dermatology. 2015.
- Nofal E, et al. Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for Facial Hyperhidrosis. 2022.
This article is for general educational purposes and does not replace an individualized medical evaluation, diagnosis, or treatment plan.